Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) High Quality

Short Description:

Chemical Name: Ethyl Nipecotate

CAS: 5006-62-2

Appearance: Colorless to Pale Yellow Liquid

Assay: ≥99.0% (GC)

High Quality, Commercial Production

E-mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Supply with High Purity and Stable Quality
Chemical Name: Ethyl Nipecotate 
CAS: 5006-62-2 
High Quality, Commercial Production

Chemical Properties:

Chemical Name Ethyl Nipecotate
Synonyms Ethyl 3-Piperidinecarboxylate; Ethyl piperidine-3-carboxylate; 3-Piperidinecarboxylic Acid Ethyl Ester
CAS Number 5006-62-2
CAT Number RF-PI271
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C8H15NO2
Molecular Weight 157.21
Melting Point 165.0~167.0℃ 
Boiling Point  102-104℃ /7 mmHg (lit.)
Density 1.012 g/mL at 25℃ (lit.)
Refractive Index  n20/D 1.460 (lit.)
Water Solubility Miscible
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Colorless to Pale Yellow Liquid
Water ≤0.50%
Single Impurity ≤0.50%
Total Impurities ≤1.0%
Heavy Metals  ≤20ppm
Assay ≥99.0%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Barrel, 25kg/Barrel, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ethyl Nipecotate (CAS: 5006-62-2) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis.

Application Ethyl Nipecotate (CAS: 5006-62-2) was used in the synthesis of: α,α′-bis[3-(N,N-diethylcarbamoyl)-piperidino]-p-xylene; 2-amino-4-thiazolyl derivative of 3-(iso-propyl-3-piperidinyl)phenol;

Reactant for synthesis of: Squalene synthase inhibitors; 4-aminomethyl-7,8-dihydroxycoumarines and their crown ether derivatives; Spiroimidazolidinone NPC1L1 inhibitors; Quorum sensing modulators; Selective serotonin 5-HT6 receptor antagonists; Oxazolidinone RNA-binding agents. 

  • Write your message here and send it to us